Acyclovir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
82804-005 -
Package NDC
82804-005-06 -
Package NDC
82804-005-15 -
Package NDC
82804-005-20 -
Package NDC
82804-005-21 -
Package NDC
82804-005-30 -
Package NDC
82804-005-35 -
Package NDC
82804-005-60 -
Package NDC
82804-005-90 -
Application number
ANDA210401 -
SPL ID
2ff9056b-ed65-4a2b-abb1-793b1fe9bf4c -
SPL set ID
97ed8713-4b3e-48a9-92c0-0a98ecf0485c -
UNII
X4HES1O11F -
RxCUI
197311
What the source publishes
- Labeler
- Proficient Rx LP
- Active ingredients
- Acyclovir
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Acyclovir",
"splId": "2ff9056b-ed65-4a2b-abb1-793b1fe9bf4c",
"labels": [
{
"setId": "97ed8713-4b3e-48a9-92c0-0a98ecf0485c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97ed8713-4b3e-48a9-92c0-0a98ecf0485c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97ed8713-4b3e-48a9-92c0-0a98ecf0485c"
}
],
"routes": [
"ORAL"
],
"labeler": "Proficient Rx LP",
"finished": true,
"packaging": [
{
"sample": false,
"description": "6 TABLET in 1 BOTTLE (82804-005-06)",
"package_ndc": "82804-005-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20240109"
},
{
"sample": false,
"description": "15 TABLET in 1 BOTTLE (82804-005-15)",
"package_ndc": "82804-005-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20240109"
},
{
"sample": false,
"description": "20 TABLET in 1 BOTTLE (82804-005-20)",
"package_ndc": "82804-005-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20240109"
},
{
"sample": false,
"description": "21 TABLET in 1 BOTTLE (82804-005-21)",
"package_ndc": "82804-005-21",
"identifierStatus": "well-formed",
"marketing_start_date": "20240109"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (82804-005-30)",
"package_ndc": "82804-005-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20230831"
},
{
"sample": false,
"description": "35 TABLET in 1 BOTTLE (82804-005-35)",
"package_ndc": "82804-005-35",
"identifierStatus": "well-formed",
"marketing_start_date": "20240109"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (82804-005-60)",
"package_ndc": "82804-005-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20230831"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (82804-005-90)",
"package_ndc": "82804-005-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20230831"
}
],
"productId": "82804-005_2ff9056b-ed65-4a2b-abb1-793b1fe9bf4c",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "82804-005",
"deaSchedule": null,
"genericName": "Acyclovir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACYCLOVIR",
"strength": "400 mg/1"
}
],
"applicationNumber": "ANDA210401",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230620",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000020060",
"N0000180187",
"N0000180188",
"N0000175468",
"N0000175459"
],
"upc": [
"0382804005307"
],
"unii": [
"X4HES1O11F"
],
"rxcui": [
"197311"
],
"spl_set_id": [
"97ed8713-4b3e-48a9-92c0-0a98ecf0485c"
],
"pharm_class_epc": [
"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"DNA Polymerase Inhibitors [MoA]"
],
"manufacturer_name": [
"Proficient Rx LP"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:82804-005_2ff9056b-ed65-4a2b-abb1-793b1fe9bf4c"